Fig. 4From: Comparison of denosumab and oral bisphosphonates for the treatment of glucocorticoid-induced osteoporosis: a systematic review and meta-analysisForest plots of percentage changes of BMD in total hip at 12 months (A), femoral neck at 6 months (B) and 12 months (C), and ultra-distal radius at 12 months (D) in denosumab versus bisphosphonatesBack to article page